Back to the main directory
EarningsReview / Equity
- Streamlining the company: forward or backward roll? by BNP Paribas Exane
- Evolution: Gradual recovery in electrification by BNP Paribas Exane
- Airtac (1590 TT) by HSBC
- XXL ASA (No_rec, TP: NOK) - Closing in on partnership with Frasers Group by DnB Markets
- Elektroimportøren (Hold, TP: NOK10.00) - Early signs of improvement by DnB Markets
- Systemair (Hold, TP: SEK85.00) - Negative mix likely to continue by DnB Markets
- Valuation update by DnB Markets
- Mining Momentum Monitor by BNP Paribas Exane
- Analyst Day Takeaways: Pragmatic, But Conservative Outlook? by BNP Paribas Exane
- TIM - NETCO DISPOSAL SECURED. NEXT STEPS: EXECUTION OF CMD TARGETS by Equita Sim
- US Class-8 orders +50% YoY in May’24 by BNP Paribas Exane
- INDITEX: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - BIGBEN : Plus de risques et moins de potentiel que Nacon - ACHAT, OC 5,8€ vs 4,5€ by Invest Securities
- INVEST SECURITIES - CROSSJECT : Vif succès de l'AK, les yeux rivés sur ZEPIZURE® - ACHAT vs SOUSCRIRE, OC 4,1€ by Invest Securities
- 2024 Investor Day: Delivering on ‘The Year of GA’ by BNP Paribas Exane
- Checkit - Potential bid for Crimson Tide by Edison Investment Research
- Accor to implement Amadeus’ CRS for 100% of global properties by BNP Paribas Exane
- 恩捷股份（002812 CH） by HSBC
- Still in ‘Goldilocks’ territory? by BNP Paribas Exane
- Altron - Transformation plan drives margin growth by Edison Investment Research
- AUSTRIACARD - Outlook points to H2-weighted growth by Edison Investment Research
- Considerations on Champion Sale by BNP Paribas Exane
- Paccar Investor Day: Further market share gains within the crosshairs by BNP Paribas Exane
- Mixed quarter with catalysts on the backburner by BNP Paribas Exane
- Elmera Group (Sell, TP: NOK21.00) - EBIT guidance marginally above, financing yet to be finalised by DnB Markets
- A. P. Moller - Maersk - Ride the momentum a bit longer by Danske Bank Equity Research
- Delta Electronics (2308 TT) by HSBC
- A. P. Møller Mærsk (Sell, TP: DKK9000.00) - USD3bn added to 2024 guidance by DnB Markets
- Oncopeptides (Buy, TP: SEK5.50) - Financial stability achieved by DnB Markets
- Axfood (Buy, TP: SEK330.00) - No drama in Q2e by DnB Markets
- ALK-Abello (Buy, TP: DKK165.00) - Growth opportunities remains solid by DnB Markets
- SyntheticMR - A diamond in the rough by Danske Bank Equity Research
- Day 1 - Tweets and Quotes by BNP Paribas Exane
- Systemair - Hold: Too early to get excited by Nordea
- CrowdStrike Holdings Inc (CRWD US) by HSBC
- INVEST SECURITIES - MEDESIS : Fin septembre, la croisée des chemins pour MEDESIS - NEUTRE, OC 3,3€ by Invest Securities
- INVEST SECURITIES - NACON : En bonne voie, avec Test Drive comme levier majeur - ACHAT, OC 3,8€ vs 3,0€ by Invest Securities
- INVEST SECURITIES - ORYZON GENOMICS: Après ALICE, FRIDA et PORTICO à surveiller en 2024 - ACHAT, OC 4,8€ by Invest Securities
- Invesco Asia Trust - Patiently waiting for re-rating of Chinese equities by Edison Investment Research
- INDITEX: 1Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Inditex - Déjà vu: 1Q in line, 2Q starts stronger than expected by JB Capital Markets
- Yunnan Energy Ltd (002812 CH) by HSBC
- First Look: Q1 comps miss, EPS in-line; FY24 EPS guide lowered by BNP Paribas Exane
- F3Q24 Quick Take by BNP Paribas Exane
- Apollo co-invests in Fab-34 by BNP Paribas Exane
- F3Q24 Conference Call Notes by BNP Paribas Exane
- Thor-ny macro by BNP Paribas Exane
- Q1 results: in line, but growing strongly (& 15qs) by BNP Paribas Exane
- FY Results: surprised about the surprise (& 15qs) by BNP Paribas Exane
- Arjo (Buy, TP: SEK58.00) - Q2e in line with guidance by DnB Markets